The combination of docetaxel and the somatostatin analogue lanreotide on androgen-independent docetaxel-resistant prostate cancer: experimental data.
Posted on 17 dicembre 2014
Lo Nigro C, Maffi M, Fischel JL, Formento P, Milano G, Merlano M.
BJU Int. 2008 Aug 5;102(5):622-7. doi: 10.1111/j.1464-410X.2008.07706.x. Epub 2008 May 20.